June 2021

NEWS & COLUMNS

6-7 NEWS
BMS links up with Exscientia; NICE recommends Ultomiris for NHS use

8 NEWS
First NHS patient treated with Novartis’ SMA gene therapy Zolgensma; FDA panel backs Provention Bio’s type 1 diabetes prevention drug

9 CORONAVIRUS NEWS
Moderna’s COVID-19 vaccine offers high
levels of protection for adolescents; EU takes legal steps against AZ;

10-11 CORONAVIRUS NEWS
Sanofi, GSK’s COVID-19 vaccine generates strong immune responses across all age groups; US backs proposal to waive IP protection for COVID-19 vaccines

12 DARWIN'S MEDICINE
Nature's Way – there are business lessons to be learned from biological tragedies

13 POLICY AND PUBLIC HEALTH
Maybe we can learn something from the Golem and Pygmalion effects

14 MENTAL WELL-BEING IS FOR LIFE
Helping people identify any issues that may be affecting their mental well-being is a great first step

15 PHARMA MARKETERS' BLOG
How to get your tactical mix right in the new normal

FEATURES

16-17 ANTIMICROBIAL RESISTANCE
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed

18-19 PERSONALISED MEDICINE
How early-stage clinical research is facilitating the new wave of personalised medicines

20-21 PHARMA'S PROOF OF PURPOSE
Pharma’s authentic proof of purpose influences decisions among HCPs and payers

22-27 COMMS EXCELLENCE
Mastering the art of connecting remotely during a pandemic – a year on, we look at the impact of the coronavirus pandemic on healthcare comms and the opportunities presented by a virtual future